Ildong Pharmaceutical Co., Ltd. (KRX: 249420)

Ildong Pharmaceutical Revenue

Ildong Pharmaceutical had revenue of 152.15B KRW in the quarter ending June 30, 2024, a decrease of -1.26%. This brings the company's revenue in the last twelve months to 603.86B, down -1.92% year-over-year. In the year 2023, Ildong Pharmaceutical had annual revenue of 600.76B, down -5.80%.

• Revenue (ttm): 603.86B
• Revenue Growth: -1.92%
• P/S Ratio: 0.56
• Revenue / Employee: 592.02M
• Employees: 1,020
• Market Cap: 343.85B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	600.76B	-36.96B	-5.80%
Dec 31, 2022	637.71B	77.58B	13.85%
Dec 31, 2021	560.13B	-1.71B	-0.30%
Dec 31, 2020	561.85B	44.38B	8.58%
Dec 31, 2019	517.47B	13.56B	2.69%